Ardent Health Investors Face Class Action Over Alleged Accounting Missteps and Stock Collapse

Ardent Health Faces Serious Legal Challenge

Ardent Health, Inc. (NYSE: ARDT), a healthcare service provider, is currently under scrutiny following allegations of serious accounting malpractices that have prompted a securities class action. The law firm Hagens Berman has announced that it is representing investors who may have suffered financial losses connected to these allegations. Specifically, the class action relates to a significant $97 million accounting shock, which became evident in November 2025 and involved significant changes to the company's financial reporting practices.

Background of the Allegations

The core of the allegations centers on what has been termed the "180-Day Cliff," a methodology allegedly used by Ardent to reserve against uncollectible accounts receivable. Critics argue that this practice is inconsistent with the company’s earlier assertions regarding its accounting procedures, specifically the claim that it employed detailed historical collection reviews to determine the value of its receivables. According to the complaint, the use of such a rigid system resulted in inflated receivables reported during the relevant period.

As a consequence of these revelations, Ardent Health witnessed a staggering 33% drop in its stock price just after the announcement of the new accounting practices. This significant devaluation raised alarm bells among investors, many of whom have now turned to legal action for damages.

Key Events Leading Up to the Class Action

1. Stock Collapse: Following the disclosure in November 2025 about the accounting methodology, Ardent faced a dramatic stock fall, losing nearly 34% of its market value in a matter of days. Investors were shocked to learn that the company had underestimated its potential liabilities, exposing it to increased financial risk.

2. Change in Revenue Accounting: On November 12, 2025, Ardent Health revealed it had shifted its accounting methods for estimating collectability of accounts receivable. This abrupt transition led to a substantial $42.6 million revenue revision, forcing investors to reassess the company’s financial health and future profitability.

3. Increased Liability Reserves: The same disclosure also included a $54 million increase in professional liability reserves, reflective of broader industry trends and ongoing litigation pressures for claims dating back several years. These factors have collectively raised concerns about Ardent’s long-term financial stability and its corporate governance practices.

Legal Implications

The complaint filed against Ardent Health claims violations of U.S. securities laws, asserting that the company and its executives failed to disclose significant risks regarding its accounting practices and financial position. The upcoming lead plaintiff deadline for the class action is set for March 9, 2026, placing pressure on investors who believe they have been affected to act swiftly in seeking legal recourse.

Reed Kathrein, a leading partner at Hagens Berman, commented on the situation, stating that the allegations suggest Ardent may have manipulated its earnings to present a stronger financial position than was warranted. Investors who acquired shares of ARDT between July 18, 2024, and November 12, 2025, are encouraged to take note of this pending action and consider their options.

Next Steps for Investors

Affected investors are urged to contact Hagens Berman to discuss the possibility of being part of the class action. The firm specializes in complex securities litigation and has a track record of advocating for shareholders. Hagens Berman has already commenced its investigation into Ardent Health and is actively advising those impacted by the recent disclosures.

To learn more about the class action and evaluate potential losses, investors can navigate to Hagens Berman's dedicated Ardent Health case page. For further information or to report losses, they can reach out to the firm directly through the secure contact forms provided.

Conclusion

As Ardent Health prepares to defend itself against serious allegations that could have long-lasting implications on its business and stock performance, the outcome of this case holds significance not only for its investors but also for the broader healthcare financial landscape. Stakeholders are poised to watch closely as this situation unfolds in the coming months.